Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark Bedford
Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition
Cancer Research
Cancer Research
Oncology
Host Protein BAG3 Is a Negative Regulator of Lassa VLP Egress
Diseases
Related publications
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
Cancer Discovery
Oncology
Synergistic Induction of Cell Death in Haematological Malignancies by Combined Phosphoinositide-3-Kinase and BET Bromodomain Inhibition
British Journal of Haematology
Hematology
Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-Terminal Domain (BET) Proteins
BET Bromodomain Inhibition Enhances T Cell Persistence and Function in Adoptive Immunotherapy Models
Journal of Clinical Investigation
Medicine
BET Bromodomain Inhibition Releases the Mediator Complex From Select Cis-Regulatory Elements
Cell Reports
Biochemistry
Genetics
Molecular Biology
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition
Cancer Research
Cancer Research
Oncology
BET Bromodomain Proteins Are Therapeutic Targets in CRPC
Cancer Discovery
Oncology
BET Bromodomain Inhibition Promotes De-Repression of TXNIP and Activation of ASK1-MAPK Pathway in Acute Myeloid Leukemia
BMC Cancer
Cancer Research
Oncology
Genetics
Inhibition of Bromodomain and Extra-Terminal Proteins (BET) as a Potential Therapeutic Approach in Haematological Malignancies: Emerging Preclinical and Clinical Evidence
Therapeutic Advances in Hematology
Hematology
